Boston Scientific (Marlborough, Mass.) launched a new product for the gastrointestinal cancer market and flexed its innovation muscle through an alliance with The Innovation Lab (Newport Beach, Calif.), an incubator that sources ideas from staff among member-owned hospitals across the U.S. from concept stage, to prototypes and end products.
The list of Medtronic's (Dublin) acquisitions since its merger with Covidien continues to rapidly expand. This time the company is picking up Lazarus Effect, (Campbell, Calif.), a private company focused on products that facilitate the capture and removal of clots, in an all cash-transaction valued at $100 million.
Zeltiq Aesthetics (Pleasanton, Calif.) made a tremendous leap forward with its fat-freezing lipoplasty technology this week. The med-tech company received an expanded indication for its Coolmini applicator to treat smaller pockets of fat including the submental, or chin fat area, more commonly referred to as the double chin.
For years, executives at Penumbra (Alameda, Calif.) avoided traditional venture capital funding. That decision allowed the company to have a much longer term view in developing technology to help stroke patients, said Adam Elsesser, chairman/CEO of Penumbra. Now the 11-year-old business, which develops devices that treat patients with neurological and vascular conditions, is making the move from a private company to a public one.
